MaaT Pharma
@maatpharma.bsky.social
MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival.
Pinned
📰 [PressRelease] – We’re thrilled to announce that our Phase 3 results evaluating Xervyteg® (MaaT013) in acute Graft-versus-Host Disease (#aGvHD) have been selected for oral presentation at ASH Congress 2025.
👉 Read the full press release: www.maatpharma.com/november-3-2...
👉 Read the full press release: www.maatpharma.com/november-3-2...
📰 MaaT Pharma featured in Drug Discovery World for promising preclinical results of our anti-tumor microbiotherapy MaaT034! This is an important milestone in our mission to transform cancer treatment with microbiome-based therapies.
👉 Read the full article here: www.ddw-online.com/maat-pharma-...
👉 Read the full article here: www.ddw-online.com/maat-pharma-...
MaaT Pharma releases positive results for anti-tumour candidate - Drug Discovery World (DDW)
Biotechnology company MaaT Pharma has announced preclinical results for its drug candidate MaaT034, including promising anti-tumour efficacy results and immune activation.
www.ddw-online.com
November 19, 2025 at 11:22 AM
📰 MaaT Pharma featured in Drug Discovery World for promising preclinical results of our anti-tumor microbiotherapy MaaT034! This is an important milestone in our mission to transform cancer treatment with microbiome-based therapies.
👉 Read the full article here: www.ddw-online.com/maat-pharma-...
👉 Read the full article here: www.ddw-online.com/maat-pharma-...
📅 Rencontrez le management de MaaT Pharma lors du Salon Investir Day le 25 novembre 2025, sur le stand L36 !
🦠 Eric Soyer prendra la parole lors d’une intervention sur le thème « Construire un leader du microbiote : la stratégie de MaaT Pharma ».
📍 Carrousel du Louvre, 99 rue de Rivoli, 75001 Paris
🦠 Eric Soyer prendra la parole lors d’une intervention sur le thème « Construire un leader du microbiote : la stratégie de MaaT Pharma ».
📍 Carrousel du Louvre, 99 rue de Rivoli, 75001 Paris
November 18, 2025 at 11:18 AM
📅 Rencontrez le management de MaaT Pharma lors du Salon Investir Day le 25 novembre 2025, sur le stand L36 !
🦠 Eric Soyer prendra la parole lors d’une intervention sur le thème « Construire un leader du microbiote : la stratégie de MaaT Pharma ».
📍 Carrousel du Louvre, 99 rue de Rivoli, 75001 Paris
🦠 Eric Soyer prendra la parole lors d’une intervention sur le thème « Construire un leader du microbiote : la stratégie de MaaT Pharma ».
📍 Carrousel du Louvre, 99 rue de Rivoli, 75001 Paris
📅 Fiers de participer au 24ème congrès annuel de la SFGM-TC 2025, à Genève !
🔬 Nous présenterons à nouveau des données cliniques issues du programme EAP sous la forme d’une communication orale, ainsi que deux posters dédiés à MaaT013 et MaaT033.
🔎 Toutes les informations dans le visuel ci-dessous 👇
🔬 Nous présenterons à nouveau des données cliniques issues du programme EAP sous la forme d’une communication orale, ainsi que deux posters dédiés à MaaT013 et MaaT033.
🔎 Toutes les informations dans le visuel ci-dessous 👇
November 17, 2025 at 11:20 AM
📅 Fiers de participer au 24ème congrès annuel de la SFGM-TC 2025, à Genève !
🔬 Nous présenterons à nouveau des données cliniques issues du programme EAP sous la forme d’une communication orale, ainsi que deux posters dédiés à MaaT013 et MaaT033.
🔎 Toutes les informations dans le visuel ci-dessous 👇
🔬 Nous présenterons à nouveau des données cliniques issues du programme EAP sous la forme d’une communication orale, ainsi que deux posters dédiés à MaaT013 et MaaT033.
🔎 Toutes les informations dans le visuel ci-dessous 👇
📰 [#PressRelease] - MaaT Pharma announces the successful completion of its Global Offering of €9.1 million
👉 www.maatpharma.com/november-14-...
👉 www.maatpharma.com/november-14-...
November 14, 2025 at 10:29 PM
📰 [#PressRelease] - MaaT Pharma announces the successful completion of its Global Offering of €9.1 million
👉 www.maatpharma.com/november-14-...
👉 www.maatpharma.com/november-14-...
📰 [#PressRelease] – MaaT Pharma Launches a Capital Increase of Approximately €9 Million
👉 Read the press release: www.maatpharma.com/november-13-...
👉 Read the press release: www.maatpharma.com/november-13-...
November 13, 2025 at 8:36 PM
📰 [#PressRelease] – MaaT Pharma Launches a Capital Increase of Approximately €9 Million
👉 Read the press release: www.maatpharma.com/november-13-...
👉 Read the press release: www.maatpharma.com/november-13-...
📰 MaaT Pharma To Present Updated Preclinical Data at SITC (@sitcancer.bsky.social) 2025.
We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models.
👉 Full press release: www.maatpharma.com/november-5-2...
We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models.
👉 Full press release: www.maatpharma.com/november-5-2...
November 5, 2025 at 6:45 AM
📰 MaaT Pharma To Present Updated Preclinical Data at SITC (@sitcancer.bsky.social) 2025.
We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models.
👉 Full press release: www.maatpharma.com/november-5-2...
We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models.
👉 Full press release: www.maatpharma.com/november-5-2...
📰 [PressRelease] – We’re thrilled to announce that our Phase 3 results evaluating Xervyteg® (MaaT013) in acute Graft-versus-Host Disease (#aGvHD) have been selected for oral presentation at ASH Congress 2025.
👉 Read the full press release: www.maatpharma.com/november-3-2...
👉 Read the full press release: www.maatpharma.com/november-3-2...
November 5, 2025 at 5:09 AM
📰 [PressRelease] – We’re thrilled to announce that our Phase 3 results evaluating Xervyteg® (MaaT013) in acute Graft-versus-Host Disease (#aGvHD) have been selected for oral presentation at ASH Congress 2025.
👉 Read the full press release: www.maatpharma.com/november-3-2...
👉 Read the full press release: www.maatpharma.com/november-3-2...
📄 [#PressRelease] - MaaT Pharma Reports Financial Results for the Third Quarter 2025 and Provides Financing Update
📍Next stops: SITC, SFGM-TC, Investir Day, ASH – see you there!
👉 Read the full press release: www.maatpharma.com/november-4-2...
📍Next stops: SITC, SFGM-TC, Investir Day, ASH – see you there!
👉 Read the full press release: www.maatpharma.com/november-4-2...
November 4, 2025 at 6:53 AM
📄 [#PressRelease] - MaaT Pharma Reports Financial Results for the Third Quarter 2025 and Provides Financing Update
📍Next stops: SITC, SFGM-TC, Investir Day, ASH – see you there!
👉 Read the full press release: www.maatpharma.com/november-4-2...
📍Next stops: SITC, SFGM-TC, Investir Day, ASH – see you there!
👉 Read the full press release: www.maatpharma.com/november-4-2...
📢 Proud to see our lead candidate MaaT013 highlighted in a new review in Current Opinion in Immunology by E. Godefroy and F. Altare, exploring how the gut microbiota regulates immune responses in acute graft-versus-host disease (#aGvHD).
🔬Open-access article: www.sciencedirect.com/science/arti...
🔬Open-access article: www.sciencedirect.com/science/arti...
October 30, 2025 at 11:28 AM
📢 Proud to see our lead candidate MaaT013 highlighted in a new review in Current Opinion in Immunology by E. Godefroy and F. Altare, exploring how the gut microbiota regulates immune responses in acute graft-versus-host disease (#aGvHD).
🔬Open-access article: www.sciencedirect.com/science/arti...
🔬Open-access article: www.sciencedirect.com/science/arti...
📢 Meet Sheri Simmons, Acting Chief Scientific Officer at MaaT Pharma, during the Annual Meeting of the SITC in National Harbor, Maryland, USA.
🔬 On Friday, November 7, Sheri will present our preclinical findings on MaaT034, our next generation co-cultured microbiome ecosystem therapy candidate.
🔬 On Friday, November 7, Sheri will present our preclinical findings on MaaT034, our next generation co-cultured microbiome ecosystem therapy candidate.
October 28, 2025 at 11:02 AM
📢 Meet Sheri Simmons, Acting Chief Scientific Officer at MaaT Pharma, during the Annual Meeting of the SITC in National Harbor, Maryland, USA.
🔬 On Friday, November 7, Sheri will present our preclinical findings on MaaT034, our next generation co-cultured microbiome ecosystem therapy candidate.
🔬 On Friday, November 7, Sheri will present our preclinical findings on MaaT034, our next generation co-cultured microbiome ecosystem therapy candidate.
Proud to share that MaaT013 (Xervyteg®) clinical data were featured in the latest special issue on acute Graft-versus-Host Disease (#aGvHD) in Current Opinion in Immunology.
🔗Open-access article here: sciencedirect.com/science/arti...
#AlloHCT #Hematology
🔗Open-access article here: sciencedirect.com/science/arti...
#AlloHCT #Hematology
Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions
Acute graft-versus-host disease (aGVHD) is a significant complication of allogeneic hematopoietic cell transplantation (allo-HCT), characterized by im…
sciencedirect.com
October 23, 2025 at 12:23 PM
Proud to share that MaaT013 (Xervyteg®) clinical data were featured in the latest special issue on acute Graft-versus-Host Disease (#aGvHD) in Current Opinion in Immunology.
🔗Open-access article here: sciencedirect.com/science/arti...
#AlloHCT #Hematology
🔗Open-access article here: sciencedirect.com/science/arti...
#AlloHCT #Hematology
📢 Join MaaT Pharma as an 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗜𝗻𝘁𝗲𝗿𝗻 (𝗠/𝗙)!
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎓 6-month internship – starting early 2026
📍 Saint-Quentin-Fallavier (France)
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎓 6-month internship – starting early 2026
📍 Saint-Quentin-Fallavier (France)
October 20, 2025 at 2:30 PM
📢 Join MaaT Pharma as an 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗜𝗻𝘁𝗲𝗿𝗻 (𝗠/𝗙)!
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎓 6-month internship – starting early 2026
📍 Saint-Quentin-Fallavier (France)
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎓 6-month internship – starting early 2026
📍 Saint-Quentin-Fallavier (France)
📢 Join MaaT Pharma as an R&D Project Manager (M/F)!
🎯 Do you have strong project management experience in the pharmaceutical or biotech industry and a passion for innovation in oncology and microbiome research? This opportunity is for you!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎯 Do you have strong project management experience in the pharmaceutical or biotech industry and a passion for innovation in oncology and microbiome research? This opportunity is for you!
🔬 Full job description: www.maatpharma.com/wp-content/u...
October 17, 2025 at 12:27 PM
📢 Join MaaT Pharma as an R&D Project Manager (M/F)!
🎯 Do you have strong project management experience in the pharmaceutical or biotech industry and a passion for innovation in oncology and microbiome research? This opportunity is for you!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎯 Do you have strong project management experience in the pharmaceutical or biotech industry and a passion for innovation in oncology and microbiome research? This opportunity is for you!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📢 [#Internship] – Join MaaT Pharma as a Quality Assurance Intern (M/F)!
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📅 6-month internship – starting January/February 2026
📍 Lyon (France)
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📅 6-month internship – starting January/February 2026
📍 Lyon (France)
October 15, 2025 at 11:32 AM
📢 [#Internship] – Join MaaT Pharma as a Quality Assurance Intern (M/F)!
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📅 6-month internship – starting January/February 2026
📍 Lyon (France)
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📅 6-month internship – starting January/February 2026
📍 Lyon (France)
📢 Join MaaT Pharma as a Biological Collection Project Manager (M/F)!
📩 Send your resume and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Detailed job description: www.maatpharma.com/wp-content/u...
#ProjectManagement #Biotech #Microbiome #Production #Quality #Regulatory
📩 Send your resume and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Detailed job description: www.maatpharma.com/wp-content/u...
#ProjectManagement #Biotech #Microbiome #Production #Quality #Regulatory
October 14, 2025 at 1:50 PM
📢 Join MaaT Pharma as a Biological Collection Project Manager (M/F)!
📩 Send your resume and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Detailed job description: www.maatpharma.com/wp-content/u...
#ProjectManagement #Biotech #Microbiome #Production #Quality #Regulatory
📩 Send your resume and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Detailed job description: www.maatpharma.com/wp-content/u...
#ProjectManagement #Biotech #Microbiome #Production #Quality #Regulatory
📢 Noémie Laurent, Chargée des ressources humaines chez MaaT Pharma, et Michèle Boyer de Zordi, chargée de Mission RSE et HSE, seront présentes au Forum emploi des industries de santé 2025, le 9 octobre à Lyon.
👉 Contribuez à faire avancer la science du microbiote : www.forumemploi-industriessante.fr
👉 Contribuez à faire avancer la science du microbiote : www.forumemploi-industriessante.fr
October 8, 2025 at 10:04 AM
📢 Noémie Laurent, Chargée des ressources humaines chez MaaT Pharma, et Michèle Boyer de Zordi, chargée de Mission RSE et HSE, seront présentes au Forum emploi des industries de santé 2025, le 9 octobre à Lyon.
👉 Contribuez à faire avancer la science du microbiote : www.forumemploi-industriessante.fr
👉 Contribuez à faire avancer la science du microbiote : www.forumemploi-industriessante.fr
📰 [PressRelease] - We’re proud to share that the DSMB has issued a positive recommendation following the second safety interim analysis of our Phase 2b PHOEBUS trial evaluating MaaT033 in patients receiving allo-HSCT.
👉 Read the full press release here: www.maatpharma.com/october-7-20...
👉 Read the full press release here: www.maatpharma.com/october-7-20...
October 7, 2025 at 5:44 AM
📰 [PressRelease] - We’re proud to share that the DSMB has issued a positive recommendation following the second safety interim analysis of our Phase 2b PHOEBUS trial evaluating MaaT033 in patients receiving allo-HSCT.
👉 Read the full press release here: www.maatpharma.com/october-7-20...
👉 Read the full press release here: www.maatpharma.com/october-7-20...
Reposted by MaaT Pharma
Some keen Observations in Our October issue!
🦠 Cancer microbiome
🌊 Marine microbes in warming oceans
🌐 broad-range phages
🧬 genetically minimised Salmonella
🔧 Viral infection mechanisms
🧪 Oxaloacetate antiviral defence
and more, here: www.nature.com/nmicrobiol/v...
🦠 Cancer microbiome
🌊 Marine microbes in warming oceans
🌐 broad-range phages
🧬 genetically minimised Salmonella
🔧 Viral infection mechanisms
🧪 Oxaloacetate antiviral defence
and more, here: www.nature.com/nmicrobiol/v...
October 1, 2025 at 5:30 PM
Some keen Observations in Our October issue!
🦠 Cancer microbiome
🌊 Marine microbes in warming oceans
🌐 broad-range phages
🧬 genetically minimised Salmonella
🔧 Viral infection mechanisms
🧪 Oxaloacetate antiviral defence
and more, here: www.nature.com/nmicrobiol/v...
🦠 Cancer microbiome
🌊 Marine microbes in warming oceans
🌐 broad-range phages
🧬 genetically minimised Salmonella
🔧 Viral infection mechanisms
🧪 Oxaloacetate antiviral defence
and more, here: www.nature.com/nmicrobiol/v...
Reposted by MaaT Pharma
Thinking about a postdoc in microbiome science?
Our lab at the MPI for Biology (Tübingen) builds on the culture I established at Cornell: collaborative, creative, and internationally diverse. Postdocs lead their own projects with secure funding. Join us!
#PostdocJobs #HostMicrobe #AcademicJobs
Our lab at the MPI for Biology (Tübingen) builds on the culture I established at Cornell: collaborative, creative, and internationally diverse. Postdocs lead their own projects with secure funding. Join us!
#PostdocJobs #HostMicrobe #AcademicJobs
October 4, 2025 at 5:37 PM
Thinking about a postdoc in microbiome science?
Our lab at the MPI for Biology (Tübingen) builds on the culture I established at Cornell: collaborative, creative, and internationally diverse. Postdocs lead their own projects with secure funding. Join us!
#PostdocJobs #HostMicrobe #AcademicJobs
Our lab at the MPI for Biology (Tübingen) builds on the culture I established at Cornell: collaborative, creative, and internationally diverse. Postdocs lead their own projects with secure funding. Join us!
#PostdocJobs #HostMicrobe #AcademicJobs
📅 Frederic Fasano, Directeur Stratégie et Développement Corporate chez MaaTPharma interviendra à la conférence annuelle du Musée de sciences biologiques Docteur Mérieux : « Vivre en Intelligences avec les Microbes ».
👉Plus d’informations : www.musee-docteur-merieux.com/conference-f...
👉Plus d’informations : www.musee-docteur-merieux.com/conference-f...
October 3, 2025 at 9:20 AM
📅 Frederic Fasano, Directeur Stratégie et Développement Corporate chez MaaTPharma interviendra à la conférence annuelle du Musée de sciences biologiques Docteur Mérieux : « Vivre en Intelligences avec les Microbes ».
👉Plus d’informations : www.musee-docteur-merieux.com/conference-f...
👉Plus d’informations : www.musee-docteur-merieux.com/conference-f...
📅 Emilie Plantamura, Directrice Médicale adjointe chez MaaT Pharma, interviendra lors du symposium « Développer une médecine du microbiote pour restaurer la symbiose hôte-microbes », organisé dans le cadre des Entretiens Jacques Cartier 2025.
👉Inscrivez-vous ici : www.billetweb.fr/developper-u...
👉Inscrivez-vous ici : www.billetweb.fr/developper-u...
October 2, 2025 at 3:00 PM
📅 Emilie Plantamura, Directrice Médicale adjointe chez MaaT Pharma, interviendra lors du symposium « Développer une médecine du microbiote pour restaurer la symbiose hôte-microbes », organisé dans le cadre des Entretiens Jacques Cartier 2025.
👉Inscrivez-vous ici : www.billetweb.fr/developper-u...
👉Inscrivez-vous ici : www.billetweb.fr/developper-u...
📅 Join Eric Soyer, CFO at MaaT Pharma, and Guilhaume Debroas, our Head of Investor Relations, at the Portzamparc Groupe BNP Paribas’ digital Biotech & Health Seminar 2025, on October 1, 2025.
#Biotech #Health #Investments #DigitalEvent #Investors #LifeSciences #Microbiome #Pharma #Portzamparc
#Biotech #Health #Investments #DigitalEvent #Investors #LifeSciences #Microbiome #Pharma #Portzamparc
September 29, 2025 at 2:42 PM
📅 Join Eric Soyer, CFO at MaaT Pharma, and Guilhaume Debroas, our Head of Investor Relations, at the Portzamparc Groupe BNP Paribas’ digital Biotech & Health Seminar 2025, on October 1, 2025.
#Biotech #Health #Investments #DigitalEvent #Investors #LifeSciences #Microbiome #Pharma #Portzamparc
#Biotech #Health #Investments #DigitalEvent #Investors #LifeSciences #Microbiome #Pharma #Portzamparc
🩸 To close #BloodCancerAwarenessMonth, we share a patient story on life-threatening #aGvHD after transplant, featured by Bloomberg with Dr. Loschi’s insights.
🎥 Watch the full story: youtu.be/P8pd0TlITpo?...
At MaaT Pharma, we advance microbiome science to tackle unmet needs in hemato-oncology.
🎥 Watch the full story: youtu.be/P8pd0TlITpo?...
At MaaT Pharma, we advance microbiome science to tackle unmet needs in hemato-oncology.
This Biotech Breakthrough Could Change Medicine
YouTube video by Bloomberg Originals
youtu.be
September 26, 2025 at 2:23 PM
🩸 To close #BloodCancerAwarenessMonth, we share a patient story on life-threatening #aGvHD after transplant, featured by Bloomberg with Dr. Loschi’s insights.
🎥 Watch the full story: youtu.be/P8pd0TlITpo?...
At MaaT Pharma, we advance microbiome science to tackle unmet needs in hemato-oncology.
🎥 Watch the full story: youtu.be/P8pd0TlITpo?...
At MaaT Pharma, we advance microbiome science to tackle unmet needs in hemato-oncology.
🎥 [Media] À l’occasion de la publication de nos résultats semestriels, notre Directeur Financier Eric Soyer est revenu sur nos derniers jalons créateurs de valeur pour Arnaud Bivès - Boursier.com.
👉 Lire l’interview complète : www.boursier.com/actions/actu...
👉 Lire l’interview complète : www.boursier.com/actions/actu...
September 23, 2025 at 3:11 PM
🎥 [Media] À l’occasion de la publication de nos résultats semestriels, notre Directeur Financier Eric Soyer est revenu sur nos derniers jalons créateurs de valeur pour Arnaud Bivès - Boursier.com.
👉 Lire l’interview complète : www.boursier.com/actions/actu...
👉 Lire l’interview complète : www.boursier.com/actions/actu...
📅 Meet Eric Soyer, Chief Financial Officer at MaaT Pharma, and Guilhaume Debroas, Head of Investor Relations at MaaT Pharma, at KBC Securities' Life Sciences Conference on Thursday, September 25, 2025, in Brussels.
#IR #Investors #Finance #Microbiome #Innovation #Pharma #Science #Healthcare #KBC
#IR #Investors #Finance #Microbiome #Innovation #Pharma #Science #Healthcare #KBC
September 22, 2025 at 10:06 AM
📅 Meet Eric Soyer, Chief Financial Officer at MaaT Pharma, and Guilhaume Debroas, Head of Investor Relations at MaaT Pharma, at KBC Securities' Life Sciences Conference on Thursday, September 25, 2025, in Brussels.
#IR #Investors #Finance #Microbiome #Innovation #Pharma #Science #Healthcare #KBC
#IR #Investors #Finance #Microbiome #Innovation #Pharma #Science #Healthcare #KBC